Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Biomarkers associated with COVID-19 disease progression

G Ponti, M Maccaferri, C Ruini, A Tomasi… - Critical reviews in …, 2020 - Taylor & Francis
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a scientific, medical, and
social challenge. The complexity of the severe acute respiratory syndrome coronavirus 2 …

Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19

N Rosenthal, Z Cao, J Gundrum, J Sianis… - JAMA network …, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) has infected more than 8.1 million US
residents and killed more than 221 000. There is a dearth of research on epidemiology and …

[HTML][HTML] A narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19

SN Rao, D Manissero, VR Steele, J Pareja - Infectious diseases and …, 2020 - Springer
Background The ability to predict likely prognosis and infectiousness for patients with COVID-
19 would aid patient management decisions. Diagnosis is usually via real-time PCR, and it …

Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19

AV Kulkarni, P Kumar, HV Tevethia… - Alimentary …, 2020 - Wiley Online Library
Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …

[HTML][HTML] Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19

AS Chan, A Rout - Journal of clinical medicine research, 2020 - ncbi.nlm.nih.gov
Background As the pandemic of coronavirus disease 2019 (COVID-19) continues,
prognostic markers are now being identified. The neutrophil-to-lymphocyte ratio (NLR) and …

[HTML][HTML] COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics

SA Azer - New Microbes and New Infections, 2020 - Elsevier
Abstract The novel coronavirus (COVID-19) outbreak started early in December 2019 in the
Hubei province and its capital Wuhan of the People's Republic of China and caused a …

[HTML][HTML] T cells: warriors of SARS-CoV-2 infection

P de Candia, F Prattichizzo, S Garavelli… - Trends in …, 2021 - cell.com
Severe infection with severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is
characterized by massive cytokine release and T cell loss. The exaggerated host immune …

[HTML][HTML] Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis

X Feng, S Li, Q Sun, J Zhu, B Chen, M Xiong… - Frontiers in …, 2020 - frontiersin.org
Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

[HTML][HTML] The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review

X Qiu, AI Nergiz, AE Maraolo, II Bogoch, N Low… - Clinical microbiology …, 2021 - Elsevier
Background Reports suggest that asymptomatic individuals (those with no symptoms at all
throughout infection) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …